Test-positive subjects | Test-negative subjects | Controls (for case–control design 2) | |||||||
---|---|---|---|---|---|---|---|---|---|
Overall | Autoimmune status | Overall | Autoimmune status | Overall | Autoimmune status | ||||
No | Yes | No | Yes | No | Yes | ||||
n = 20,364 | n = 19,699 96.7% | n = 665 3.3% | n = 34,697 | n = 33,400 96.3% | n = 1297 3.7% | n = 81,414 | n = 79,245 97.3% | n = 2169 2.7% | |
Gender = Male (%) | 9666 (47.5) | 9496 (48.2) | 170 (25.6) | 13,658 (39.4) | 13,438 (40.2) | 220 (17) | 38,659 (47.5) | 38,127 (48.1) | 532 (24.5) |
Age mean (sd) | 65.5 (19.4) | 65.6 (19.5) | 64.5 (16.1) | 54.8 (20.8) | 54.8 (20.95) | 56.9 (16.4) | 65.5 (19.4) | 65.5 (19.5) | 66.2 (16.1) |
Age class (years) (%) | |||||||||
< 17 | 171 (0.8) | 170 (0.9) | 1 (0.2) | 905 (2.6) | 902 (2.7) | 3 (0.2) | 684 (0.8) | 682 (0.9) | 2 (0.1) |
[18–40) | 1907 (9.4) | 1868 (9.5) | 39 (5.9) | 7521 (21.7) | 7353 (22) | 168 (13) | 7629 (9.4) | 7512 (9.5) | 117 (5.4) |
[40–70) | 8622 (42.3) | 8264 (42) | 358 (53.8) | 17,047 (49.1) | 16,241 (48.6) | 806 (62.1) | 34,488 (42.4) | 33,452 (42.2) | 1036 (47.8) |
≥ 70 | 9664 (47.5) | 9397 (47.7) | 267 (40.2) | 9224 (26.6) | 8904 (26.7) | 320 (24.7) | 38,613 (47.4) | 37,599 (47.4) | 1014 (46.7) |
Geographic location (%) | |||||||||
Lodi province (start of the outburst) | 2939 (14.4) | 2836 (14.4) | 103 (15.5) | 5185 (14.9) | 5001 (15) | 184 (14.2) | 11,675 (14.3) | 11,356 (14.3) | 319 (14.7) |
City of Milan | 7235 (35.5) | 7025 (35.7) | 210 (31.6) | 13,188 (38) | 12,761 (38.2) | 427 (32.9) | 29,185 (35.8) | 28,437 (35.9) | 748 (34.5) |
Milan province | 10,190 (50) | 9838 (49.9) | 352 (52.9) | 16,324 (47) | 15,638 (46.8) | 686 (52.9) | 40,554 (49.8) | 39,452 (49.8) | 1102 (50.8) |
Setting (%) | |||||||||
Home | 6122 (30.1) | 5861 (29.8) | 261 (39.2) | – | – | – | – | – | – |
Residential | 3381 (16.6) | 3319 (16.8) | 62 (9.3) | – | – | – | – | – | – |
Residential followed by hospitalization | 556 (2.7) | 548 (2.8) | 8 (1.2) | – | – | – | – | – | – |
Hospitalized | 10,305 (50.6) | 9971 (50.6) | 334 (50.2) | – | – | – | – | – | – |
Health status | |||||||||
Non-hospitalized and alive | 8292 (40.7) | 7998 (40.6) | 294 (44.2) | – | – | – | – | – | – |
Hospitalized and alive | 7949 (39.0) | 7692 (39.0) | 257 (38.6) | – | – | – | – | – | – |
Deceased | 4123 (20.2) | 4009 (20.4) | 114 (17.1) | – | – | – | – | – | – |
Number of comorbidities (Excluded autoimmune diseases) | |||||||||
None | 8265 (40.6) | 8105 (41.1) | 160 (24.1) | 18,870 (54.4) | 18,457 (55.3) | 413 (31.8) | 36,658 (45) | 36,131 (45.6) | 527 (24.3) |
1–3 | 8951 (44) | 8581 (43.6) | 370 (55.6) | 11,959 (34.5) | 11,286 (33.8) | 673 (51.9) | 36,156 (44.4) | 34,862 (44) | 1294 (59.7) |
≥ 4 | 3148 (15.5) | 3013 (15.3) | 135 (20.3) | 3868 (11.1) | 3657 (10.9) | 211 (16.3) | 8600 (10.6) | 8252 (10.4) | 348 (16) |
Comorbidities (%) | |||||||||
Transplanted any time = Yes (%) | 77 (0.4) | 75 (0.4) | 2 (0.3) | 227 (0.7) | 221 (0.7) | 6 (0.5) | 159 (0.2) | 155 (0.2) | 4 (0.2) |
Blood and Hematopoietic organs = Yes (%) | 30 (0.1) | 27 (0.1) | 3 (0.5) | 64 (0.2) | 57 (0.2) | 7 (0.5) | 85 (0.1) | 80 (0.1) | 5 (0.2) |
HIV infection or AIDS = Yes (%) | 72 (0.4) | 72 (0.4) | 0 (0) | 224 (0.6) | 220 (0.7) | 4 (0.3) | 261 (0.3) | 259 (0.3) | 2 (0.1) |
Tumor in first line treatment = Yes (%) | 1024 (5) | 923 (4.7) | 101 (15.2) | 2027 (5.8) | 1869 (5.6) | 158 (12.2) | 3303 (4.1) | 3023 (3.8) | 280 (12.9) |
Tumor in follow-up, 1–5 years = Yes (%) | 788 (3.9) | 759 (3.9) | 29 (4.4) | 1128 (3.3) | 1071 (3.2) | 57 (4.4) | 3153 (3.9) | 3050 (3.8) | 103 (4.7) |
Tumor in remission after 5 years = Yes (%) | 1087 (5.3) | 1038 (5.3) | 49 (7.4) | 1337 (3.9) | 1269 (3.8) | 68 (5.2) | 4238 (5.2) | 4088 (5.2) | 150 (6.9) |
Type 1 diabetes = Yes (%) | 28 (0.1) | 28 (0.1) | 0 (0) | 79 (0.2) | 76 (0.2) | 3 (0.2) | 58 (0.1) | 54 (0.1) | 4 (0.2) |
Type 2 diabetes = Yes (%) | 2426 (11.9) | 2357 (12) | 69 (10.4) | 2537 (7.3) | 2434 (7.3) | 103 (7.9) | 7660 (9.4) | 7433 (9.4) | 227 (10.5) |
Complicated DM Type 1 and 2 = Yes (%) | 423 (2.1) | 408 (2.1) | 15 (2.3) | 527 (1.5) | 503 (1.5) | 24 (1.9) | 750 (0.9) | 722 (0.9) | 28 (1.3) |
Hypercholesterolaemia = Yes (%) | 2301 (11.3) | 2216 (11.2) | 85 (12.8) | 2614 (7.5) | 2495 (7.5) | 119 (9.2) | 9607 (11.8) | 9306 (11.7) | 301 (13.9) |
Arterial hypertension = Yes (%) | 8187 (40.2) | 7896 (40.1) | 291 (43.8) | 9454 (27.2) | 9016 (27) | 438 (33.8) | 32,202 (39.6) | 31,267 (39.5) | 935 (43.1) |
Ischemic heart disease = Yes (%) | 2364 (11.6) | 2297 (11.7) | 67 (10.1) | 2744 (7.9) | 2617 (7.8) | 127 (9.8) | 7497 (9.2) | 7273 (9.2) | 224 (10.3) |
Valvular heart disease = Yes (%) | 475 (2.3) | 458 (2.3) | 17 (2.6) | 678 (2) | 647 (1.9) | 31 (2.4) | 1328 (1.6) | 1287 (1.6) | 41 (1.9) |
Cardiomyopathy with arrhythmia = Yes (%) | 2310 (11.3) | 2241 (11.4) | 69 (10.4) | 2614 (7.5) | 2503 (7.5) | 111 (8.6) | 6850 (8.4) | 6634 (8.4) | 216 (10) |
Cardiomyopathy without arrhythmia = Yes (%) | 1699 (8.3) | 1641 (8.3) | 58 (8.7) | 2025 (5.8) | 1941 (5.8) | 84 (6.5) | 5278 (6.5) | 5129 (6.5) | 149 (6.9) |
Chronic hearth failure = Yes (%) | 1401 (6.9) | 1346 (6.8) | 55 (8.3) | 1764 (5.1) | 1680 (5) | 84 (6.5) | 3567 (4.4) | 3463 (4.4) | 104 (4.8) |
Peripheral artery disease = Yes (%) | 595 (2.9) | 573 (2.9) | 22 (3.3) | 820 (2.4) | 784 (2.3) | 36 (2.8) | 1334 (1.6) | 1290 (1.6) | 44 (2) |
Venous diseases = Yes (%) | 201 (1) | 192 (1) | 9 (1.4) | 281 (0.8) | 259 (0.8) | 22 (1.7) | 580 (0.7) | 562 (0.7) | 18 (0.8) |
Cerebrovascular disease = Yes (%) | 822 (4) | 799 (4.1) | 23 (3.5) | 932 (2.7) | 884 (2.6) | 48 (3.7) | 1653 (2) | 1607 (2) | 46 (2.1) |
Thyroid diseases = Yes (%) | 1137 (5.6) | 783 (4) | 354 (53.2) | 2149 (6.2) | 1357 (4.1) | 792 (61.1) | 4106 (5) | 2872 (3.6) | 1234 (56.9) |
Other endocrine diseases = Yes (%) | 78 (0.4) | 70 (0.4) | 8 (1.2) | 173 (0.5) | 150 (0.4) | 23 (1.8) | 225 (0.3) | 211 (0.3) | 14 (0.6) |
Other autoimmune diseases = Yes (%) | 359 (1.8) | 22 (0.1) | 337 (50.7) | 601 (1.7) | 47 (0.1) | 554 (42.7) | 1095 (1.3) | 63 (0.1) | 1032 (47.6) |
Epilepsy = Yes (%) | 271 (1.3) | 257 (1.3) | 14 (2.1) | 393 (1.1) | 380 (1.1) | 13 (1) | 598 (0.7) | 577 (0.7) | 21 (1) |
Alzheimer and dementias = Yes (%) | 669 (3.3) | 655 (3.3) | 14 (2.1) | 579 (1.7) | 562 (1.7) | 17 (1.3) | 989 (1.2) | 968 (1.2) | 21 (1) |
Parkinson and parkinsonisms = Yes (%) | 310 (1.5) | 305 (1.5) | 5 (0.8) | 287 (0.8) | 279 (0.8) | 8 (0.6) | 616 (0.8) | 596 (0.8) | 20 (0.9) |
Nervous system diseases, others = Yes (%) | 99 (0.5) | 94 (0.5) | 5 (0.8) | 232 (0.7) | 218 (0.7) | 14 (1.1) | 263 (0.3) | 257 (0.3) | 6 (0.3) |
Chronic hepatitis and cirrhosis = Yes (%) | 433 (2.1) | 413 (2.1) | 20 (3) | 705 (2) | 666 (2) | 39 (3) | 1293 (1.6) | 1248 (1.6) | 45 (2.1) |
Digestive system diseases, others = Yes (%) | 254 (1.2) | 243 (1.2) | 11 (1.7) | 459 (1.3) | 434 (1.3) | 25 (1.9) | 763 (0.9) | 710 (0.9) | 53 (2.4) |
COPD = Yes (%) | 897 (4.4) | 864 (4.4) | 33 (5) | 1089 (3.1) | 1039 (3.1) | 50 (3.9) | 2433 (3) | 2345 (3) | 88 (4.1) |
RF or oxygen therapy = Yes (%) | 97 (0.5) | 91 (0.5) | 6 (0.9) | 151 (0.4) | 142 (0.4) | 9 (0.7) | 221 (0.3) | 207 (0.3) | 14 (0.6) |
Asthma = Yes (%) | 443 (2.2) | 422 (2.1) | 21 (3.2) | 833 (2.4) | 776 (2.3) | 57 (4.4) | 1369 (1.7) | 1303 (1.6) | 66 (3) |
CKD = Yes (%) | 590 (2.9) | 557 (2.8) | 33 (5) | 716 (2.1) | 681 (2) | 35 (2.7) | 1464 (1.8) | 1409 (1.8) | 55 (2.5) |
Dialysis dependent CKD = Yes (%) | 151 (0.7) | 147 (0.7) | 4 (0.6) | 443 (1.3) | 427 (1.3) | 16 (1.2) | 122 (0.1) | 121 (0.2) | 1 (0) |
Autoimmune diseases | |||||||||
Acquired autoimmune hemolytic anemia | – | – | 10 (1.5) | – | – | 11 (0.8) | – | – | 19 (0.9) |
Systemic sclerosis | – | – | 21 (3.2) | – | – | 47 (3.6) | – | – | 51 (2.4) |
Ankylosing spondylitis | – | – | 13 (2) | – | – | 22 (1.7) | – | – | 42 (1.9) |
Myasthenia gravis | – | – | 20 (3) | – | – | 21 (1.6) | – | – | 39 (1.8) |
Rheumatoid arthritis | – | – | 167 (25.1) | – | – | 223 (17.2) | – | – | 479 (22.1) |
Psoriatic arthritis | – | – | 69 (10.4) | – | – | 139 (10.7) | – | – | 284 (13.1) |
Systemic lupus erythematosus | – | – | 16 (2.4) | – | – | 38 (2.9) | – | – | 57 (2.6) |
Sjögren disease | – | – | 26 (3.9) | – | – | 60 (4.6) | – | – | 70 (3.2) |
Hashimoto’s disease | – | – | 323 (48.6) | – | – | 736 (56.7) | – | – | 1128 (52.0) |